Home    Back

 169. Menkes disease
 [ 5 clinical trials,    5 drugs（DrugBank: 4 drugs),    0 target gene / 0 target pathway ] 

Searched query = "Menkes disease"
The queries were searched in Public_title, Scientific_title, and Condition of the data. Export date: 11/20/2019, 11/21/2019. Trials are sorted by Date_enrolment from most recent to oldest in the table.

Search in Page    e.g. "Phase 3", "Not recruiting", "Japan"
No.TrialIDDate_
enrollement		Last_Refreshed_
on		Public_titleScientific_titleConditionInterventionPrimary_
sponsor		Secondary_
sponsor		Recruitment_
Status		Inclusion_
agemin		Inclusion_
agemax		Inclusion_
gender		Target_
size		PhaseCountries
1NCT04074512August 29, 201916 September 2019Copper Histidinate Treatment for Menkes DiseaseCopper Histidinate Treatment for Menkes DiseaseMenkes DiseaseDrug: Copper HistidinateCyprium Therapeutics, Inc.Not recruitingN/A6 YearsAllPhase 4
2JPRN-UMIN0000306262014/11/282 April 2019Investigation on the effectiveness of histidine copper treatment of Menkes disease patientsMenkes diseaseWeekly,subcutaneous injection of histidine copper (750microgram once) is performed three times per week.It is continued every week until the end of the research during the research period.Hamamatsu University School of MedicineNot RecruitingNot applicableNot applicableMale and Female2Not selectedJapan
3JPRN-UMIN0000052592011/03/032 April 2019Clinical trial of histidine-copper and diethyldithiocarbamate combination therapy for patients with Menkes diseaseMenkes diseasegive a dose of copper-histidine and diethyldithiocarbamateKobe Unniversitu Graduate School of MedicineNot RecruitingNot applicableNot applicableMale and Female2Not selectedJapan
4NCT00811785February 27, 200926 August 2019Molecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper DeficiencyMolecular Bases of Response to Copper Treatment in Menkes Disease, Related Phenotypes, and Unexplained Copper DeficiencyMenkes Disease;Occipital Horn Syndrome;Unexplained Copper DeficiencyDrug: Copper HistidineEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)National Center for Complementary and Integrative Health (NCCIH)Not recruitingN/A80 YearsAll93Phase 3United States
5NCT00001262June 199019 October 2017Copper Histidine Therapy for Menkes DiseasesEarly Copper Histidine Therapy in Menkes DiseaseKinky Hair SyndromeDrug: Copper HistidineEunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)Not recruitingN/AN/AAll60Phase 1/Phase 2United States

Back to top